Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Kovsie first-years get ready for great things
2011-01-16

Prof. Jonathan Jansen (Vice-Chancellor and Rector of the UFS) with two of the first-year students.
- Photo: Lize-Mare Smit

“One thing I can assure you: here academic work comes first.” This was how Prof. Jonathan Jansen, Vice-Chancellor and Rector of the University of the Free State (UFS), set first-years parents’ minds at ease during the welcoming events of the first-years on the Main Campus the past weekend. 

The welcoming events, which took place over two days, were attended by a total of 7 000 first-years and their parents from across the country. 
 
Prof. Jansen also told the students and their parents that they were at the best place, by sharing his excitement about all the new students who decided to come and study at Kovsies. “You have overcome major obstacles in order to be here today,” he said at the welcoming.
 
With more than 90% new students who comply with admission requirements, this group of students promises to become true leaders of South Africa.
 
Prof. Jansen shared a few plans for the year with the audience. “As in 2010, we shall once again send a group of first-year students to universities later this year, not only in America, but amongst others also to Europe and Asian countries, amongst others, to learn more about different cultures and diversity. We aim to double the number of students who will be selected to 150 this year.” We can also look forward to, amongst others, a brand-new entrance and gymnasium for the Main Campus and four new hostels, two of which will be built on the Qwaqwa Campus.
 
Prof. Jansen emphasised the seriousness with which academic work had to be regarded, by referring to the compulsory class attendance that was implemented last year. “Since the inception of this arrangement in 2010, there was a 30% increase in students’ pass rate,” he said.
 
This year, for the first time, honorary awards were also given to young people who had rendered an exceptional service to the community. Anél Kleingeld, a 10-year-old learner from Trompsburg, and Mpho Phahlo from the UFS’s Unit for Students with Disabilities proudly received these awards. Anél made a remarkable contribution to George’s community when she encouraged learners from her` school to collect and deliver 700 litres of water for this community. Mpho made a point of assisting and motivating persons with disabilities at Kovsies to work hard on a daily basis.
 
 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept